Erxin Shang

6.7k total citations · 1 hit paper
227 papers, 5.3k citations indexed

About

Erxin Shang is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Erxin Shang has authored 227 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 85 papers in Complementary and alternative medicine and 47 papers in Pharmacology. Recurrent topics in Erxin Shang's work include Traditional Chinese Medicine Analysis (62 papers), Metabolomics and Mass Spectrometry Studies (37 papers) and Natural product bioactivities and synthesis (37 papers). Erxin Shang is often cited by papers focused on Traditional Chinese Medicine Analysis (62 papers), Metabolomics and Mass Spectrometry Studies (37 papers) and Natural product bioactivities and synthesis (37 papers). Erxin Shang collaborates with scholars based in China, United States and Macao. Erxin Shang's co-authors include Jin‐Ao Duan, Dawei Qian, Jianming Guo, Yuping Tang, Shulan Su, Shu Jiang, Zhenhua Zhu, Jin‐Ao Duan, Sheng Guo and Pei Liu and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Erxin Shang

222 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The relationship between polysaccharide structure and its antioxidant activity needs to be systematically elucidated

2024 106 citations Nuo Chen, Erxin Shang et al. International Journal of Biological Macromolecules profile →

Peers

Erxin Shang

CAM

PHARM

Wei Peng China

Zhiqiang Liu China

Dawei Qian China

Zhenzhong Wang China

Wei Xiao China

Haixue Kuang China

Bing‐You Yang China

Katsuko Komatsu Japan

Peigen Xiao China

Kaishun Bi China

Wei Peng China

Erxin Shang

2.6k ×0.9

990 ×0.8

CAM

1.4k ×1.3

1.1k ×1.0

PHARM

627 ×0.9

Citations per year, relative to Erxin Shang Erxin Shang (= 1×) peers Wei Peng

Countries citing papers authored by Erxin Shang

Since Specialization

Citations

This map shows the geographic impact of Erxin Shang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erxin Shang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erxin Shang more than expected).

Fields of papers citing papers by Erxin Shang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erxin Shang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erxin Shang. The network helps show where Erxin Shang may publish in the future.

Co-authorship network of co-authors of Erxin Shang

This figure shows the co-authorship network connecting the top 25 collaborators of Erxin Shang. A scholar is included among the top collaborators of Erxin Shang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erxin Shang. Erxin Shang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Mingyang, et al.. (2025). Integrated network pharmacology and metabolomics analysis to reveal the potential mechanism of Ershen Wan in ameliorating ulcerative colitis. Journal of Ethnopharmacology. 346. 119690–119690.

Liu, Pei, Yang He, Guang Yu, et al.. (2025). Untargeted metabolomics and functional analyses reveal that the secondary metabolite quinic acid associates with Angelica sinensis flowering. BMC Plant Biology. 25(1). 72–72. 1 indexed citations

Zhang, Xiaoyu, Yani Wang, Pei Liu, et al.. (2024). Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation. Journal of Ethnopharmacology. 325. 117869–117869. 3 indexed citations

Chen, Nuo, et al.. (2024). The relationship between polysaccharide structure and its antioxidant activity needs to be systematically elucidated. International Journal of Biological Macromolecules. 270(Pt 2). 132391–132391. 106 indexed citations breakdown →

Zhou, Guoliang, et al.. (2024). Exploring the liver toxicity mechanism of Tripterygium wilfordii extract based on metabolomics, network pharmacological analysis and experimental validation. Journal of Ethnopharmacology. 337(Pt 2). 118888–118888. 6 indexed citations

Wang, Yu, Yun Zhang, Wenwen Li, et al.. (2024). Multi-omics combined to explore the purging mechanism of Rhei Radix et Rhizoma and Magnoliae Officinalis Cortex. Journal of Chromatography B. 1243. 124218–124218. 1 indexed citations

Xu, Mingming, Lu Fan, Xinyi Wei, et al.. (2023). Structurally diverse (9β-H)-pimarane derivatives with six frameworks from the leaves of Icacina oliviformis and their cytotoxic activities. Phytochemistry. 214. 113804–113804.

Lu, Youyuan, Sheng Guo, Fang Zhang, et al.. (2020). Nutritional components characterization of Goji berries from different regions in China. Journal of Pharmaceutical and Biomedical Analysis. 195. 113859–113859. 37 indexed citations

Chen, Jiaqian, Yan‐Yan Chen, Zong‐Jin Pu, et al.. (2019). An integrated metabolomics strategy to reveal dose-effect relationship and therapeutic mechanisms of different efficacy of rhubarb in constipation rats. Journal of Pharmaceutical and Biomedical Analysis. 177. 112837–112837. 26 indexed citations

10.

Wei, Xiaoyan, Jinhua Tao, Shu Jiang, et al.. (2018). Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota. Scientific Reports. 8(1). 3685–3685. 221 indexed citations

11.

Jin, Yi, Yuping Tang, Zhenhua Zhu, et al.. (2017). Pharmacokinetic Comparison of Seven Major Bio-Active Components in Normal and Blood Stasis Rats after Oral Administration of Herb Pair Danggui-Honghua by UPLC-TQ/MS. Molecules. 22(10). 1746–1746. 18 indexed citations

12.

Qu, Cheng, Linyan Wang, Yuping Tang, et al.. (2016). Comparative Analysis of the Effects of Hydroxysafflor Yellow A and Anhydrosafflor Yellow B in Safflower Series of Herb Pairs Using Prep-HPLC and a Selective Knock-Out Approach. Molecules. 21(11). 1480–1480. 21 indexed citations

13.

Qu, Cheng, Linyan Wang, Hang Lin, et al.. (2016). Hierarchical identification of bioactive components in a medicinal herb by preparative high-performance liquid chromatography and selective knock-out strategy. Journal of Pharmaceutical and Biomedical Analysis. 135. 206–216. 15 indexed citations

14.

Li, Jianping, Jianming Guo, Erxin Shang, et al.. (2015). A metabolomics strategy to explore urinary biomarkers and metabolic pathways for assessment of interaction between Danhong injection and low-dose aspirin during their synergistic treatment. Journal of Chromatography B. 1026. 168–175. 7 indexed citations

15.

Zhao, Min, Jun Xu, Dawei Qian, et al.. (2014). Ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry for determination of avicularin metabolites produced by a human intestinal bacterium. Journal of Chromatography B. 949-950. 30–36. 13 indexed citations

16.

Yao, Xin, Guisheng Zhou, Yuping Tang, et al.. (2014). Quercetin-3-O-β-D-glucopyranosyl-(4→1)-α-L-rhamnoside metabolites in the rat using UPLC-Q-TOF/MS. Chinese Journal of Natural Medicines. 12(9). 705–711. 2 indexed citations

17.

Liu, Pei, Jin‐Ao Duan, Peijuan Wang, et al.. (2012). Biomarkers of primary dysmenorrhea and herbal formula intervention: an exploratory metabonomics study of blood plasma and urine. Molecular BioSystems. 9(1). 77–87. 53 indexed citations

18.

Ding, Wen, Dawei Qian, Pei Liu, et al.. (2012). [Influence of different solutions on extracting of active components in Danggui Chishao drug pair].. PubMed. 37(7). 916–9. 2 indexed citations

19.

Ma, Hongyue, Jing Zhou, Erxin Shang, et al.. (2012). Interactions between bufadienolides derived from toad venom and verapamil in langendorff-perfused guinea-pig hearts. Toxicology in Vitro. 27(1). 396–401. 5 indexed citations

20.

Shang, Erxin, et al.. (2005). Determination of phenazopyridine in human plasma via LC–MS and subsequent development of a pharmacokinetic model. Analytical and Bioanalytical Chemistry. 382(1). 216–222. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact